Trials / Completed
CompletedNCT04099927
A Study of SHR4010 in Patients With Hemodialysis
A Phase I, Open-label Clinical Study on Safety and Pharmacokinetics of SHR0410 Injection for Multiple Administration in Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety and pharmacokinetics of SHR0410 in patients with hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0410 | SHR0410 monotherapy,given intravenously |
Timeline
- Start date
- 2019-07-28
- Primary completion
- 2020-04-20
- Completion
- 2020-06-15
- First posted
- 2019-09-23
- Last updated
- 2022-08-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04099927. Inclusion in this directory is not an endorsement.